Skip to main content

Day: December 4, 2019

Auction details treasury bills

Auction date December 11, 2019                     Settlement date December 13, 2019Bids have to be entered by 11.00 on December 11, 2019Bid only through dealers approved by the Swedish National Debt OfficeFor more information, please contact: The funding desk+ 46 8 613 4780Fo@riksgalden.se

Continue reading

Nemaura Medical Announces 1 for 10 Reverse Split Intended to Attract a Wider Universe of Institutional Investors

Loughborough, England, Dec. 04, 2019 (GLOBE NEWSWIRE) —  Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on the commercialization of SugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by diabetics and pre-diabetics, today announced plans to conduct reverse stock split of the Company’s issued and outstanding common stock, par value $0.001 per share on a one 1 for 10 basis.  The reverse split is expected to take effect at the market open on December 5, 2019. The new CUSIP number will be 640442208.In accordance with the reverse split, each stockholder’s percentage ownership interest in Nemaura Medical remains unchanged. Any fractional shares resulting from the reverse stock split were rounded up to the nearest whole share of common stock. As a result,...

Continue reading

Nasdaq CEO Adena Friedman to Present at Goldman Sachs U.S. Financial Services Conference 2019

NEW YORK, Dec. 04, 2019 (GLOBE NEWSWIRE) —About NasdaqNasdaq (Nasdaq: NDAQ) is a global technology company serving the capital markets and other industries. Our diverse offering of data, analytics, software and services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions and career opportunities, visit us on LinkedIn, on Twitter @Nasdaq, or at www.nasdaq.com.Media Relations Contacts:Allan Schoenberg(212) 231-5534allan.schoenberg@nasdaq.comWill Briganti(678) 504-6097william.briganti@nasdaq.comInvestor Relations Contact:Ed Ditmire, CFA(212) 401-8737ed.ditmire@nasdaq.com-NDAQF- 

Continue reading

Growlife Releases Shareholder Letter from CEO Addressing Reverse Split and Upcoming Initiatives

KIRKLAND, Wash., Dec. 04, 2019 (GLOBE NEWSWIRE) — GrowLife, Inc. (OTC: PHOT) (“GrowLife” or the “Company”), one of the nation’s most recognized indoor cultivation product and service providers, released the following letter today from the Company’s Chief Executive Officer Marco Hegyi.Dear Shareholders,I would like to take this opportunity to discuss some of the most recent developments within GrowLife from a financial and operational standpoint.  We have had a very exciting year to-date – from the successful integration of industry-renowned EZ-CLONE Enterprises, which allowed us to surpass our 2018 annual revenue in just over six months of 2019, to the retirement of over a half-billion shares and subsequent reversal of shares, 2019 has proved to be one of the most pivotal and important years from a strategic positioning stand-point...

Continue reading

Itamar™ Medical and SoClean® Announce Collaboration to Offer WatchPAT™ ONE and other Digital Health Services Through Direct-to-Consumer Channels

Collaboration Will Endeavor to Reach Millions Suffering from Undiagnosed and Untreated Sleep Apnea SufferersCAESAREA, Israel and PETERBOROUGH, N.H., Dec. 04, 2019 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), ( “Itamar Medical”) a company that develops, manufactures and markets non-invasive ambulatory diagnostic medical devices for sleep apnea and offers Total Sleep Solution using a cloud based digital health platform, and SoClean Inc., a company that develops, manufactures and markets sleep equipment sanitizers through direct-to-consumer (DTC) channels to the sleep apnea market, today announced a collaboration agreement between their respective wholly owned subsidiaries to make Itamar Medical’s WatchPAT ONE home sleep apnea test and Digital Health Services available to consumers. The collaboration is designed...

Continue reading

AS Tallinna Vesi signed a contract for the partial reconstruction of the mechanical treatment equipment at the wastewater treatment plant

Tallinna Vesi signed a contract today for the partial reconstruction of the mechanical treatment process stage at the wastewater treatment plant in Paljassaare. The contract was awarded to RVT Ehitus OÜ and Osaühing Mapri Ehitus who submitted a joint tender. The total cost of the project will be €7.6 million, which was the result of a competitive tender.The reconstruction mainly focuses at increasing the reliability of the mechanical treatment stage within the wastewater treatment process. The works will include the construction of the new grit separation tanks and the associated facilities, and also upgrading the existing technological equipment. The planned timeline for completion of the project is Q4 2022.Eliis VennikHead of Customer Relations and CommunicationTallinna Vesi(+372) 626 2275Eliis.vennik@tvesi.ee

Continue reading

AS Tallinna Vesi sõlmis lepingu reoveepuhasti mehaanilise puhastuse osaliseks rekonstrueerimiseks

Täna sõlmis Tallinna Vesi hankelepingu Paljassaare reoveepuhastusjaama mehaanilise puhastusetapi osaliseks rekonstrueerimiseks. Hanke võitjaks tunnistati RVT Ehitus OÜ ja Osaühing Mapri Ehitus ühispakkumus. Projekti maksumuseks kujunes hanke käigus 7,6 miljonit eurot.Rekonstrueerimise peamine eesmärk on reoveepuhastuse mehaanilise puhastusetapi töökindluse tõstmine. Tööde käigus rajatakse uued liivaeraldusbasseinid ja nendega kaasnevad rajatised ning ajakohastatakse ka olemasolevaid tehnoloogilisi seadmeid. Tööde eeldatav valmimisaeg on 2022. aasta 4. kvartal. Eliis VennikKliendisuhete ja Kommunikatsiooni juhtTallinna Vesi(+372) 626 2275Eliis.vennik@tvesi.ee

Continue reading

Appian, nombrada ‘elección de cliente’ en la categoría de plataforma empresarial de desarrollo de aplicación low-code por Gartner Peer Insights en noviembre de 2019

TYSONS, Va., Dec. 04, 2019 (GLOBE NEWSWIRE) — Appian (NASDAQ: APPN) anuncia que ha sido nombrada como la elección de los usuarios de Gartner Peer Insights 2019 en la categoría de Plataformas de aplicaciones Low-Code empresariales.Según Gartner, las plataformas de desarrollo de aplicación low-code para empresas (Enterprise Low-Code Application Platforms, sus siglas en inglés LCAP) “soportan el rápido desarrollo de aplicación, el despliegue en un paso, la ejecución y la gestión utilizando abstracciones de alto nivel declarativas como lenguajes de programación basados en metadatos e impulsados por modelos”. El Cuadrante Mágico de Plataformas de aplicación low-code empresariales de Gartner posiciona a Appian como líder del mercado y prevé que el desarrollo de aplicación low-code representará más del 65% de la actividad de desarrollo...

Continue reading

Lykill fjármögnun hf.: Bill auction on 10 December 2019

Lykill fjármögnun hf. (Lykill) will conduct a bill auction next Tuesday, 10 December 2019. A new 6-month bill series LYKILL200615 will be offered in the auction.Fossar Markets is to manage the auction and will present it to potential investors. The auction will be closed with a Dutch method, where all bills will be sold at the highest yield accepted. Lykill reserves the right to accept any offer partially or in full or refuse all offers. The auction results will be made public no later than the next business day following the auction.Bids are accepted until 17:00 (GMT+0) on Tuesday, 10 December 2019. Settlement day is planned to be on 16 December 2019. Bids must be sent to utbod@fossarmarkets.com.Prospectus, final terms and other documents concerning the issue of the bills above are published on the company’s website: https://www.lykill.is/functions/fjarfestatengsl/.Contacts:Dadi...

Continue reading

Lykill fjármögnun: Útboð á víxlum 10. desember 2019

Lykill fjármögnun hf. efnir til útboðs á víxlum þriðjudaginn 10. desember 2019. Boðnir verða til sölu víxlar í nýjum 6 mánaða flokki LYKILL200615.Fossar markaðir hf. hafa umsjón með útboðinu og kynna það fyrir hugsanlegum fjárfestum. Útboðið verður með hollenskri aðferð, þ.e. öll samþykkt tilboð bjóðast fjárfestum á hæstu flötu vöxtum sem tekið er. Víxlarnir eru gefnir út í 20 m.kr. nafnverðseiningum og verða skráðir í Kauphöll. Félagið áskilur sér rétt til þess að taka hvaða tilboði sem er eða hafna þeim öllum. Niðurstöður útboðsins verða birtar opinberlega eigi síðar en næsta virka dag eftir útboð.Tekið er við tilboðum til kl. 17:00 þriðjudaginn 10. desember og uppgjör viðskipta fer fram þann 16. desember 2019. Tilboðum skal skilað á netfangið utbod@fossarmarkets.com.Útboðið er lokað og undanþegið gerð lýsingar, sbr. 1. mgr., 1. tl....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.